Back
Bristol-Myers Squibb Vs. Biogen Industry Stock Comparison
Sell
35
BMY
Bristol-Myers Squibb
Last Price:
43.87
Seasonality Move:
0.31%
Buy
51
BIIB
Biogen
Last Price:
221.00
Seasonality Move:
6.6%
Sell
35
Bristol-Myers Squibb (BMY)
is a Sell
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $43.67. The Score for BMY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- BMY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Biogen (BIIB)
is a Buy
Is Biogen a Buy, Sell or Hold?
- The current Biogen [BIIB] share price is $219.72. The Score for BIIB is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- BIIB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $43.67
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMY is experiencing selling pressure, which indicates risk of future bearish movement.
BIIB Stock Price Chart
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.88 | Sell |
| Relative Strength Index (14 RSI): | 25.5 | Sell |
| Chaikin Money Flow: | -7781092 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.55 - 50.13) | Sell |
| Bollinger Bands (100): | (47.65 - 52.63) | Sell |
BIIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.77 | Buy |
| Relative Strength Index (14 RSI): | 62.55 | Buy |
| Chaikin Money Flow: | 152069 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (195.78 - 214.72) | Buy |
| Bollinger Bands (100): | (208.25 - 248.85) | Sell |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.01 | Sell |
| 20-day SMA: | 46.39 | Sell |
| 50-day SMA: | 49.89 | Sell |
| 200-day SMA: | 53.35 | Sell |
| 8-day EMA: | 44.37 | Sell |
| 20-day EMA: | 46.2 | Sell |
| 50-day EMA: | 48.5 | Sell |
| 200-day EMA: | 53.6 | Sell |
BIIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 217.21 | Buy |
| 20-day SMA: | 205.46 | Buy |
| 50-day SMA: | 211.94 | Buy |
| 200-day SMA: | 240.92 | Sell |
| 8-day EMA: | 215.89 | Buy |
| 20-day EMA: | 210.87 | Buy |
| 50-day EMA: | 213.93 | Buy |
| 200-day EMA: | 237.04 | Sell |
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.22 per share, a decrease this year of $6.86 per share, and an increase next year of $6.41 per share.
Biogen Earnings Growth & BIIB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.03 per share, an increase this year of $0.62 per share, and an increase next year of $1.73 per share.
Bristol-Myers Squibb Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biogen Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||